Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Junior Gold Miners (GDXJ) vs HCA Health Inc (HCA) Price & Performance

VanEck Junior Gold MinersTrade
HCA Health IncTrade

Price performance (Past 24H)

Key statistics

VanEck Junior Gold Miners vs HCA Health Inc — how do they compare? VanEck Junior Gold Miners trades at $119.25, while HCA Health Inc trades at $416.82 (market cap $89.08B). The key difference: HCA Health Inc pays a 0.76% dividend while VanEck Junior Gold Miners pays none, and VanEck Junior Gold Miners is trading nearer its 52-week high, HCA Health Inc nearer its low. Which is the better fit depends on your goals.

GDXJHCA
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$156.19$545.13
52-Week Low
$71.22$361.32
Market Cap
$89.08B
Enterprise Value
$139.62B
Dividend Yield
0.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Junior Gold Miners

GDXJ, the VanEck Junior Gold Miners ETF, trades at $119.18, up 0.34% on the day, with a bullish technical signal driven by moving averages but tempered by overbought oscillators. Recent news highlights institutional selling and underperformance versus peers, while the ETF's composition shows less small-cap exposure than advertised. Key support lies at $118, with resistance at $120.

The outlook is mixed: bullish momentum persists near-term, but high RSI readings and negative sentiment from articles like Seeking Alpha (2026-06-24) suggest caution. Risks include gold price volatility and Federal Reserve policy shifts, while institutional activity, such as Amundi's 50.5% stake reduction (Defense World, 2026-08-06), indicates skepticism.

HCA Health Inc

HCA Healthcare trades at $413.27, down 0.18% on the day, with strong technical momentum showing a bullish moving average signal. The company reported solid Q2 2026 earnings with EPS of $7.59 beating estimates of $7.56, marking the third consecutive quarterly beat. Revenue growth continues with 2025 revenue reaching $75.60 billion, while maintaining healthy profit margins of 8.77%. Recent management appointments and ongoing legal investigations create mixed sentiment around the stock.

HCA presents a compelling value opportunity with attractive valuation multiples (P/E 13.8, EV/EBITDA 8.8) and strong analyst support (63% buy ratings, $449.93 price target). However, investors face risks from multiple ongoing legal investigations, high debt levels (debt-to-asset ratio 80.9% in 2025), and margin pressure from rising operational costs. The stock offers 8.9% upside to consensus target but requires monitoring of legal developments and expense management.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Junior Gold Miners

GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.

Read more on GDXJ

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA